Matches in Nanopublications for { ?s ?p "[FST is known to be an inhibitor of bone morphogenetic proteins (BMPs), which, coupled with the ability of TGF-?2 to upregulate FST levels, may indicate a possible role of FST in the pathogenesis of glaucoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP651733.RAy9oN_R2lCuQO1PRD2clrC3rWbrEYPZun0lNYje_GVpk130_assertion description "[FST is known to be an inhibitor of bone morphogenetic proteins (BMPs), which, coupled with the ability of TGF-?2 to upregulate FST levels, may indicate a possible role of FST in the pathogenesis of glaucoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651733.RAy9oN_R2lCuQO1PRD2clrC3rWbrEYPZun0lNYje_GVpk130_provenance.
- NP733381.RAY3Ae8p2xWCeSXfI0juWLS0R8ZXq1BcQQ533Qu_IZ7oQ130_assertion description "[FST is known to be an inhibitor of bone morphogenetic proteins (BMPs), which, coupled with the ability of TGF-?2 to upregulate FST levels, may indicate a possible role of FST in the pathogenesis of glaucoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP733381.RAY3Ae8p2xWCeSXfI0juWLS0R8ZXq1BcQQ533Qu_IZ7oQ130_provenance.
- assertion description "[FST is known to be an inhibitor of bone morphogenetic proteins (BMPs), which, coupled with the ability of TGF-?2 to upregulate FST levels, may indicate a possible role of FST in the pathogenesis of glaucoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[FST is known to be an inhibitor of bone morphogenetic proteins (BMPs), which, coupled with the ability of TGF-?2 to upregulate FST levels, may indicate a possible role of FST in the pathogenesis of glaucoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1015665.RAiy9QngXB9nWjpy5bLfo3YnGiaFlD94kTkEl_LznN2eM130_assertion description "[FST is known to be an inhibitor of bone morphogenetic proteins (BMPs), which, coupled with the ability of TGF-?2 to upregulate FST levels, may indicate a possible role of FST in the pathogenesis of glaucoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1015665.RAiy9QngXB9nWjpy5bLfo3YnGiaFlD94kTkEl_LznN2eM130_provenance.
- NP844137.RANMxQnqIaCcqfGQ01AeVgrQ68zPN0GvpyQz89-XNU0lo130_assertion description "[FST is known to be an inhibitor of bone morphogenetic proteins (BMPs), which, coupled with the ability of TGF-?2 to upregulate FST levels, may indicate a possible role of FST in the pathogenesis of glaucoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP844137.RANMxQnqIaCcqfGQ01AeVgrQ68zPN0GvpyQz89-XNU0lo130_provenance.
- NP1015664.RAxQQbtXECS2ntlt3AzBksvVqZY17CxYlSmmMdY9gINf4130_assertion description "[FST is known to be an inhibitor of bone morphogenetic proteins (BMPs), which, coupled with the ability of TGF-?2 to upregulate FST levels, may indicate a possible role of FST in the pathogenesis of glaucoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1015664.RAxQQbtXECS2ntlt3AzBksvVqZY17CxYlSmmMdY9gINf4130_provenance.